137 related articles for article (PubMed ID: 11008878)
1. N-methyl(R)salsolinol and a neutral N-methyltransferase as pathogenic factors in Parkinson's disease.
Maruyama W; Strolin-Benedetti M; Naoi M
Neurobiology (Bp); 2000; 8(1):55-68. PubMed ID: 11008878
[TBL] [Abstract][Full Text] [Related]
2. (R)salsolinol N-methyltransferase activity increases in parkinsonian lymphocytes.
Naoi M; Maruyama W; Nakao N; Ibi T; Sahashi K; Benedetti MS
Ann Neurol; 1998 Feb; 43(2):212-6. PubMed ID: 9485062
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis of idiopathic Parkinson's disease].
Maruyama W
Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):494-7. PubMed ID: 11523160
[TBL] [Abstract][Full Text] [Related]
4. A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in Parkinsonian cerebrospinal fluid.
Maruyama W; Abe T; Tohgi H; Dostert P; Naoi M
Ann Neurol; 1996 Jul; 40(1):119-22. PubMed ID: 8687181
[TBL] [Abstract][Full Text] [Related]
5. Cell death of dopamine neurons in aging and Parkinson's disease.
Naoi M; Maruyama W
Mech Ageing Dev; 1999 Nov; 111(2-3):175-88. PubMed ID: 10656535
[TBL] [Abstract][Full Text] [Related]
6. A neutral N-methyltransferase activity in the striatum determines the level of an endogenous MPP+-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains.
Naoi M; Maruyama W; Matsubara K; Hashizume Y
Neurosci Lett; 1997 Oct; 235(1-2):81-4. PubMed ID: 9389601
[TBL] [Abstract][Full Text] [Related]
7. An endogenous MPTP-like dopaminergic neurotoxin, N-methyl(R)salsolinol, in the cerebrospinal fluid decreases with progression of Parkinson's disease.
Maruyama W; Abe T; Tohgi H; Naoi M
Neurosci Lett; 1999 Feb; 262(1):13-6. PubMed ID: 10076861
[TBL] [Abstract][Full Text] [Related]
8. Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
Naoi M; Maruyama W; Akao Y; Yi H
Neurotoxicol Teratol; 2002; 24(5):579-91. PubMed ID: 12200189
[TBL] [Abstract][Full Text] [Related]
9. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
Naoi M; Maruyama W; Nagy GM
Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
[TBL] [Abstract][Full Text] [Related]
10. Cell death in Parkinson's disease.
Maruyama W; Naoi M
J Neurol; 2002 Sep; 249 Suppl 2():II6-10. PubMed ID: 12375057
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.
Naoi M; Maruyama W; Akao Y; Zhang J; Parvez H
Toxicology; 2000 Nov; 153(1-3):123-41. PubMed ID: 11090952
[TBL] [Abstract][Full Text] [Related]
12. A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain.
Maruyama W; Sobue G; Matsubara K; Hashizume Y; Dostert P; Naoi M
Neurosci Lett; 1997 Feb; 223(1):61-4. PubMed ID: 9058423
[TBL] [Abstract][Full Text] [Related]
13. N-methyl(R)salsolinol, a dopamine neurotoxin, in Parkinson's disease.
Naoi M; Maruyama W
Adv Neurol; 1999; 80():259-64. PubMed ID: 10410730
[No Abstract] [Full Text] [Related]
14. N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
Naoi M; Maruyama W; Dostert P; Hashizume Y
J Neural Transm Suppl; 1997; 50():89-105. PubMed ID: 9120428
[TBL] [Abstract][Full Text] [Related]
15. [Salsolinol, 3-O-methyl-dopa and homovanillic acid in the cerebrospinal fluid of Parkinson patients].
Krygowska-Wajs A; Szczudlik A; Antkiewicz-Michaluk L; Romańska I; Vetulani J
Neurol Neurochir Pol; 1997; 31(5):875-85. PubMed ID: 9513952
[TBL] [Abstract][Full Text] [Related]
16. [Studies on endogenous toxins as pathogenic factors in idiopathic parkinson's disease].
Maruyama W; Naoi M
Nihon Yakurigaku Zasshi; 2000 Dec; 116(6):333-42. PubMed ID: 11188501
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, is mediated by activation of caspase 3.
Akao Y; Nakagawa Y; Maruyama W; Takahashi T; Naoi M
Neurosci Lett; 1999 Jun; 267(3):153-6. PubMed ID: 10380999
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
Naoi M; Maruyama W; Kasamatsu T; Dostert P
J Neural Transm Suppl; 1998; 52():125-38. PubMed ID: 9564615
[TBL] [Abstract][Full Text] [Related]
19. Involvement of endogenous N-methyl(R)salsolinol in Parkinson's disease: induction of apoptosis and protection by (-)deprenyl.
Naoi M; Maruyama W; Takahashi T; Akao Y; Nakagawa Y
J Neural Transm Suppl; 2000; (58):111-21. PubMed ID: 11128601
[TBL] [Abstract][Full Text] [Related]
20. Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid.
Maruyama W; Narabayashi H; Dostert P; Naoi M
J Neural Transm (Vienna); 1996; 103(8-9):1069-76. PubMed ID: 9013394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
